The structural profiles are close, with Constellation Energy carrying a narrow edge on growth. AstraZeneca still leads on profitability and stability, which keeps the comparison from looking entirely one-sided. In the market, AstraZeneca carries the stronger setup — intact trend against Constellation Energy's broken trend. That leaves a split case: the structural lead stays with Constellation Energy, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Nasdaq 100 universe, making them directly comparable.
The comparison is mainly decided in growth, with the rest of the profile carrying less weight.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
A loose similarity means the comparison is still methodologically valid, but the structural overlap is limited.
Most of the shared profile comes through revenue growth trajectory and margin trend.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
The structural gap is limited here, but current pricing still leans against AstraZeneca PLC.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where AZN and CEG each sit in their own 4.3-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.
AstraZeneca PLC still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
Growth gives Constellation Energy Corporation the clearer edge, even though stability and the price setup keep the overall picture from looking clean.
Break down the AZN vs CEG comparison across all dimensions with the full interactive tool.
Explore how AZN and CEG each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.